Literature DB >> 16550956

Epidemiological aspects of olfactory dysfunction.

Andrea Ciofalo1, Franco Filiaci, Raffaello Romeo, Giampietro Zambetti, Anna Rita Vestri.   

Abstract

PURPOSE: This study aimed at assessing the most common aetiological factors causing total or partial olfactory deficit and the statistical analysis of some clinical aspects.
MATERIALS AND METHODS: 243 patients reporting alfactory dysfunction were enrolled in this STUDY: A case history was drawn up for each patient, and all of them underwent otolaryngology objective examination, including nasal endoscopy, paranasal sinuses CT-scan, and Utrecht method (GITU) based smell indentification test.
RESULTS: Upper respiratory viral infections (40.2%), ceanial-facial traumas (39.3%), and rhinosinusal pathologies (6.3%) were the main aetiopathological factors indentified. A relevant number of case were recorded with unknown aetiology (14.2%). In 2 cases, olfactory dysfunction was due to neurological diseases, in 1 case it was due to intoxication and, in another case, it was congenital. The correlation between aetiology, gender, age, symptoms duration and deficit severity was studied.
CONCLUSIONS: many different aetiological factors caused the loss or weakening of the sense of smell. They mainly affected olfactory neurosensorial structures and odorant conduction. However, there were many cases of unknown aetiology. Women, over 40 in particular, were the most affected. Anosmia and severe hyposmia were mainly correlated with traumas and viral pathologies.

Entities:  

Mesh:

Year:  2006        PMID: 16550956

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  8 in total

1.  Olfactory dysfunction in acute rhinosinusitis: intranasal sodium hyaluronate as adjuvant treatment.

Authors:  Andrea Ciofalo; Marco de Vincentiis; Giampietro Zambetti; Giancarlo Altissimi; Massimo Fusconi; Antonio Greco; Giancarlo Ottaviano; Giuseppe Magliulo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-27       Impact factor: 2.503

2.  Perspectives on population-based epidemiological studies of olfactory and taste impairment.

Authors:  Howard J Hoffman; Karen J Cruickshanks; Barry Davis
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

3.  Excessive Expression of Microglia/Macrophage and Proinflammatory Mediators in Olfactory Bulb and Olfactory Dysfunction After Stroke.

Authors:  Chien-Fu Yeh; Tung-Yueh Chuang; Ming-Ying Lan; Yu-Ching Chin; Wei-Hsin Wang; Yung-Yang Lin
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 4.  Clinical Implications of Psychophysical Olfactory Testing: Assessment, Diagnosis, and Treatment Outcome.

Authors:  Baihan Su; Benjamin Bleier; Yongxiang Wei; Dawei Wu
Journal:  Front Neurosci       Date:  2021-03-18       Impact factor: 4.677

5.  Patterns of Gray and White Matter Volume Alterations in Patients With Post-Traumatic Anosmia: A Voxel-Based Morphometry Study.

Authors:  Xing Gao; Baihan Su; Zhifu Sun; Lei Xu; Yongxiang Wei; Dawei Wu
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

6.  Unveiling the knowledge domain and emerging trends of olfactory dysfunction with depression or anxiety: A bibliometrics study.

Authors:  Fangwei Zhou; Tian Zhang; Ying Jin; Yifei Ma; Yangsong Li; Mengting Zeng; Guodong Yu
Journal:  Front Neurosci       Date:  2022-09-08       Impact factor: 5.152

7.  Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study).

Authors:  Joaquim Mullol; Isam Alobid; Franklin Mariño-Sánchez; Llorenç Quintó; Josep de Haro; Manuel Bernal-Sprekelsen; Antonio Valero; Cèsar Picado; Concepció Marin
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

8.  Correlation between symptoms and objective findings may improve the symptom-based diagnosis of chronic rhinosinusitis for primary care and epidemiological studies.

Authors:  Do-Yang Park; Eun Jung Lee; Ji Hoon Kim; Yoo Suk Kim; Chan Min Jung; Kyung-Su Kim
Journal:  BMJ Open       Date:  2015-12-16       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.